Discontinuation of Antiretroviral Therapy in Patients With Asymptomatic HIV Infection
Recruiting in Palo Alto (17 mi)
+33 other locations
Age: Any Age
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
No Placebo Group
Trial Summary
What is the purpose of this trial?
The purpose of this study is to determine whether patients who have asymptomatic HIV infection can discontinue antiretroviral therapy (ART) without adverse clinical, virologic, or immunologic consequences. This study will also assess the virologic, immunologic, and clinical outcomes in any patients who restart ART.
Research Team
DJ
Daniel J. Skiest, M. D.
Principal Investigator
University of Texas Southwestern Medical Center
Eligibility Criteria
Inclusion Criteria
HIV infection
ART with 2 or more drugs for 6 or more months
CD4+ cell count(s) > 350 cells/mm3 immediately prior to initiation of first ART
See 4 more
Treatment Details
Interventions
- Antiretroviral Therapy (N/A)
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Wishard HospIndianapolis, IN
The Miriam HospitalProvidence, RI
Comprehensive Care ClinicNashville, TN
Univ of North CarolinaChapel Hill, NC
More Trial Locations
Loading ...
Who Is Running the Clinical Trial?
National Institute of Allergy and Infectious Diseases (NIAID)
Lead Sponsor
Trials
3361
Patients Recruited
5,516,000+